1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Anti-obesity Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Prescription Drugs 1.2.3 OTC Drugs 1.3 Market by Application 1.3.1 Global Anti-obesity Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Men 1.3.3 Women 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Anti-obesity Medicine Market Perspective (2017-2028) 2.2 Anti-obesity Medicine Growth Trends by Region 2.2.1 Anti-obesity Medicine Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Anti-obesity Medicine Historic Market Size by Region (2017-2022) 2.2.3 Anti-obesity Medicine Forecasted Market Size by Region (2023-2028) 2.3 Anti-obesity Medicine Market Dynamics 2.3.1 Anti-obesity Medicine Industry Trends 2.3.2 Anti-obesity Medicine Market Drivers 2.3.3 Anti-obesity Medicine Market Challenges 2.3.4 Anti-obesity Medicine Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Anti-obesity Medicine Players by Revenue 3.1.1 Global Top Anti-obesity Medicine Players by Revenue (2017-2022) 3.1.2 Global Anti-obesity Medicine Revenue Market Share by Players (2017-2022) 3.2 Global Anti-obesity Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Anti-obesity Medicine Revenue 3.4 Global Anti-obesity Medicine Market Concentration Ratio 3.4.1 Global Anti-obesity Medicine Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Anti-obesity Medicine Revenue in 2021 3.5 Anti-obesity Medicine Key Players Head office and Area Served 3.6 Key Players Anti-obesity Medicine Product Solution and Service 3.7 Date of Enter into Anti-obesity Medicine Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Anti-obesity Medicine Breakdown Data by Type 4.1 Global Anti-obesity Medicine Historic Market Size by Type (2017-2022) 4.2 Global Anti-obesity Medicine Forecasted Market Size by Type (2023-2028) 5 Anti-obesity Medicine Breakdown Data by Application 5.1 Global Anti-obesity Medicine Historic Market Size by Application (2017-2022) 5.2 Global Anti-obesity Medicine Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Anti-obesity Medicine Market Size (2017-2028) 6.2 North America Anti-obesity Medicine Market Size by Type 6.2.1 North America Anti-obesity Medicine Market Size by Type (2017-2022) 6.2.2 North America Anti-obesity Medicine Market Size by Type (2023-2028) 6.2.3 North America Anti-obesity Medicine Market Share by Type (2017-2028) 6.3 North America Anti-obesity Medicine Market Size by Application 6.3.1 North America Anti-obesity Medicine Market Size by Application (2017-2022) 6.3.2 North America Anti-obesity Medicine Market Size by Application (2023-2028) 6.3.3 North America Anti-obesity Medicine Market Share by Application (2017-2028) 6.4 North America Anti-obesity Medicine Market Size by Country 6.4.1 North America Anti-obesity Medicine Market Size by Country (2017-2022) 6.4.2 North America Anti-obesity Medicine Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Anti-obesity Medicine Market Size (2017-2028) 7.2 Europe Anti-obesity Medicine Market Size by Type 7.2.1 Europe Anti-obesity Medicine Market Size by Type (2017-2022) 7.2.2 Europe Anti-obesity Medicine Market Size by Type (2023-2028) 7.2.3 Europe Anti-obesity Medicine Market Share by Type (2017-2028) 7.3 Europe Anti-obesity Medicine Market Size by Application 7.3.1 Europe Anti-obesity Medicine Market Size by Application (2017-2022) 7.3.2 Europe Anti-obesity Medicine Market Size by Application (2023-2028) 7.3.3 Europe Anti-obesity Medicine Market Share by Application (2017-2028) 7.4 Europe Anti-obesity Medicine Market Size by Country 7.4.1 Europe Anti-obesity Medicine Market Size by Country (2017-2022) 7.4.2 Europe Anti-obesity Medicine Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Anti-obesity Medicine Market Size (2017-2028) 8.2 Asia-Pacific Anti-obesity Medicine Market Size by Type 8.2.1 Asia-Pacific Anti-obesity Medicine Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Anti-obesity Medicine Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Anti-obesity Medicine Market Share by Type (2017-2028) 8.3 Asia-Pacific Anti-obesity Medicine Market Size by Application 8.3.1 Asia-Pacific Anti-obesity Medicine Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Anti-obesity Medicine Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Anti-obesity Medicine Market Share by Application (2017-2028) 8.4 Asia-Pacific Anti-obesity Medicine Market Size by Region 8.4.1 Asia-Pacific Anti-obesity Medicine Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Anti-obesity Medicine Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Anti-obesity Medicine Market Size (2017-2028) 9.2 Latin America Anti-obesity Medicine Market Size by Type 9.2.1 Latin America Anti-obesity Medicine Market Size by Type (2017-2022) 9.2.2 Latin America Anti-obesity Medicine Market Size by Type (2023-2028) 9.2.3 Latin America Anti-obesity Medicine Market Share by Type (2017-2028) 9.3 Latin America Anti-obesity Medicine Market Size by Application 9.3.1 Latin America Anti-obesity Medicine Market Size by Application (2017-2022) 9.3.2 Latin America Anti-obesity Medicine Market Size by Application (2023-2028) 9.3.3 Latin America Anti-obesity Medicine Market Share by Application (2017-2028) 9.4 Latin America Anti-obesity Medicine Market Size by Country 9.4.1 Latin America Anti-obesity Medicine Market Size by Country (2017-2022) 9.4.2 Latin America Anti-obesity Medicine Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Anti-obesity Medicine Market Size (2017-2028) 10.2 Middle East & Africa Anti-obesity Medicine Market Size by Type 10.2.1 Middle East & Africa Anti-obesity Medicine Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Anti-obesity Medicine Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Anti-obesity Medicine Market Share by Type (2017-2028) 10.3 Middle East & Africa Anti-obesity Medicine Market Size by Application 10.3.1 Middle East & Africa Anti-obesity Medicine Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Anti-obesity Medicine Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Anti-obesity Medicine Market Share by Application (2017-2028) 10.4 Middle East & Africa Anti-obesity Medicine Market Size by Country 10.4.1 Middle East & Africa Anti-obesity Medicine Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Anti-obesity Medicine Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Alizyme 11.1.1 Alizyme Company Details 11.1.2 Alizyme Business Overview 11.1.3 Alizyme Anti-obesity Medicine Introduction 11.1.4 Alizyme Revenue in Anti-obesity Medicine Business (2017-2022) 11.1.5 Alizyme Recent Developments 11.2 Amylin Pharmaceuticals 11.2.1 Amylin Pharmaceuticals Company Details 11.2.2 Amylin Pharmaceuticals Business Overview 11.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Introduction 11.2.4 Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2017-2022) 11.2.5 Amylin Pharmaceuticals Recent Developments 11.3 Arena Pharmaceuticals 11.3.1 Arena Pharmaceuticals Company Details 11.3.2 Arena Pharmaceuticals Business Overview 11.3.3 Arena Pharmaceuticals Anti-obesity Medicine Introduction 11.3.4 Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2017-2022) 11.3.5 Arena Pharmaceuticals Recent Developments 11.4 Boehringer Ingelheim 11.4.1 Boehringer Ingelheim Company Details 11.4.2 Boehringer Ingelheim Business Overview 11.4.3 Boehringer Ingelheim Anti-obesity Medicine Introduction 11.4.4 Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2017-2022) 11.4.5 Boehringer Ingelheim Recent Developments 11.5 Eisai 11.5.1 Eisai Company Details 11.5.2 Eisai Business Overview 11.5.3 Eisai Anti-obesity Medicine Introduction 11.5.4 Eisai Revenue in Anti-obesity Medicine Business (2017-2022) 11.5.5 Eisai Recent Developments 11.6 GlaxoSmithKline 11.6.1 GlaxoSmithKline Company Details 11.6.2 GlaxoSmithKline Business Overview 11.6.3 GlaxoSmithKline Anti-obesity Medicine Introduction 11.6.4 GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2017-2022) 11.6.5 GlaxoSmithKline Recent Developments 11.7 Orexigen Therapeutics 11.7.1 Orexigen Therapeutics Company Details 11.7.2 Orexigen Therapeutics Business Overview 11.7.3 Orexigen Therapeutics Anti-obesity Medicine Introduction 11.7.4 Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2017-2022) 11.7.5 Orexigen Therapeutics Recent Developments 11.8 Vivus 11.8.1 Vivus Company Details 11.8.2 Vivus Business Overview 11.8.3 Vivus Anti-obesity Medicine Introduction 11.8.4 Vivus Revenue in Anti-obesity Medicine Business (2017-2022) 11.8.5 Vivus Recent Developments 11.9 Pfizer 11.9.1 Pfizer Company Details 11.9.2 Pfizer Business Overview 11.9.3 Pfizer Anti-obesity Medicine Introduction 11.9.4 Pfizer Revenue in Anti-obesity Medicine Business (2017-2022) 11.9.5 Pfizer Recent Developments 11.10 Roche 11.10.1 Roche Company Details 11.10.2 Roche Business Overview 11.10.3 Roche Anti-obesity Medicine Introduction 11.10.4 Roche Revenue in Anti-obesity Medicine Business (2017-2022) 11.10.5 Roche Recent Developments 11.11 Merck 11.11.1 Merck Company Details 11.11.2 Merck Business Overview 11.11.3 Merck Anti-obesity Medicine Introduction 11.11.4 Merck Revenue in Anti-obesity Medicine Business (2017-2022) 11.11.5 Merck Recent Developments 11.12 Novo Nordisk 11.12.1 Novo Nordisk Company Details 11.12.2 Novo Nordisk Business Overview 11.12.3 Novo Nordisk Anti-obesity Medicine Introduction 11.12.4 Novo Nordisk Revenue in Anti-obesity Medicine Business (2017-2022) 11.12.5 Novo Nordisk Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Anti-obesity Medicine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Prescription Drugs Table 3. Key Players of OTC Drugs Table 4. Global Anti-obesity Medicine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Anti-obesity Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Anti-obesity Medicine Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Anti-obesity Medicine Market Share by Region (2017-2022) Table 8. Global Anti-obesity Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Anti-obesity Medicine Market Share by Region (2023-2028) Table 10. Anti-obesity Medicine Market Trends Table 11. Anti-obesity Medicine Market Drivers Table 12. Anti-obesity Medicine Market Challenges Table 13. Anti-obesity Medicine Market Restraints Table 14. Global Anti-obesity Medicine Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Anti-obesity Medicine Revenue Share by Players (2017-2022) Table 16. Global Top Anti-obesity Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-obesity Medicine as of 2021) Table 17. Ranking of Global Top Anti-obesity Medicine Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Anti-obesity Medicine Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Anti-obesity Medicine Product Solution and Service Table 21. Date of Enter into Anti-obesity Medicine Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Anti-obesity Medicine Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Anti-obesity Medicine Revenue Market Share by Type (2017-2022) Table 25. Global Anti-obesity Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Anti-obesity Medicine Revenue Market Share by Type (2023-2028) Table 27. Global Anti-obesity Medicine Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Anti-obesity Medicine Revenue Share by Application (2017-2022) Table 29. Global Anti-obesity Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Anti-obesity Medicine Revenue Share by Application (2023-2028) Table 31. North America Anti-obesity Medicine Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Anti-obesity Medicine Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Anti-obesity Medicine Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Anti-obesity Medicine Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Anti-obesity Medicine Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Anti-obesity Medicine Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Anti-obesity Medicine Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Anti-obesity Medicine Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Anti-obesity Medicine Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Anti-obesity Medicine Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Anti-obesity Medicine Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Anti-obesity Medicine Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Anti-obesity Medicine Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Anti-obesity Medicine Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Anti-obesity Medicine Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Anti-obesity Medicine Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Anti-obesity Medicine Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Anti-obesity Medicine Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Anti-obesity Medicine Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Anti-obesity Medicine Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Anti-obesity Medicine Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Anti-obesity Medicine Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Anti-obesity Medicine Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Anti-obesity Medicine Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Anti-obesity Medicine Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Anti-obesity Medicine Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Anti-obesity Medicine Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Anti-obesity Medicine Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Anti-obesity Medicine Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Anti-obesity Medicine Market Size by Country (2023-2028) & (US$ Million) Table 61. Alizyme Company Details Table 62. Alizyme Business Overview Table 63. Alizyme Anti-obesity Medicine Product Table 64. Alizyme Revenue in Anti-obesity Medicine Business (2017-2022) & (US$ Million) Table 65. Alizyme Recent Developments Table 66. Amylin Pharmaceuticals Company Details Table 67. Amylin Pharmaceuticals Business Overview Table 68. Amylin Pharmaceuticals Anti-obesity Medicine Product Table 69. Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2017-2022) & (US$ Million) Table 70. Amylin Pharmaceuticals Recent Developments Table 71. Arena Pharmaceuticals Company Details Table 72. Arena Pharmaceuticals Business Overview Table 73. Arena Pharmaceuticals Anti-obesity Medicine Product Table 74. Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2017-2022) & (US$ Million) Table 75. Arena Pharmaceuticals Recent Developments Table 76. Boehringer Ingelheim Company Details Table 77. Boehringer Ingelheim Business Overview Table 78. Boehringer Ingelheim Anti-obesity Medicine Product Table 79. Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2017-2022) & (US$ Million) Table 80. Boehringer Ingelheim Recent Developments Table 81. Eisai Company Details Table 82. Eisai Business Overview Table 83. Eisai Anti-obesity Medicine Product Table 84. Eisai Revenue in Anti-obesity Medicine Business (2017-2022) & (US$ Million) Table 85. Eisai Recent Developments Table 86. GlaxoSmithKline Company Details Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline Anti-obesity Medicine Product Table 89. GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2017-2022) & (US$ Million) Table 90. GlaxoSmithKline Recent Developments Table 91. Orexigen Therapeutics Company Details Table 92. Orexigen Therapeutics Business Overview Table 93. Orexigen Therapeutics Anti-obesity Medicine Product Table 94. Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2017-2022) & (US$ Million) Table 95. Orexigen Therapeutics Recent Developments Table 96. Vivus Company Details Table 97. Vivus Business Overview Table 98. Vivus Anti-obesity Medicine Product Table 99. Vivus Revenue in Anti-obesity Medicine Business (2017-2022) & (US$ Million) Table 100. Vivus Recent Developments Table 101. Pfizer Company Details Table 102. Pfizer Business Overview Table 103. Pfizer Anti-obesity Medicine Product Table 104. Pfizer Revenue in Anti-obesity Medicine Business (2017-2022) & (US$ Million) Table 105. Pfizer Recent Developments Table 106. Roche Company Details Table 107. Roche Business Overview Table 108. Roche Anti-obesity Medicine Product Table 109. Roche Revenue in Anti-obesity Medicine Business (2017-2022) & (US$ Million) Table 110. Roche Recent Developments Table 111. Merck Company Details Table 112. Merck Business Overview Table 113. Merck Anti-obesity Medicine Product Table 114. Merck Revenue in Anti-obesity Medicine Business (2017-2022) & (US$ Million) Table 115. Merck Recent Developments Table 116. Novo Nordisk Company Details Table 117. Novo Nordisk Business Overview Table 118. Novo Nordisk Anti-obesity Medicine Product Table 119. Novo Nordisk Revenue in Anti-obesity Medicine Business (2017-2022) & (US$ Million) Table 120. Novo Nordisk Recent Developments Table 121. Research Programs/Design for This Report Table 122. Key Data Information from Secondary Sources Table 123. Key Data Information from Primary Sources List of Figures Figure 1. Global Anti-obesity Medicine Market Share by Type: 2021 VS 2028 Figure 2. Prescription Drugs Features Figure 3. OTC Drugs Features Figure 4. Global Anti-obesity Medicine Market Share by Application: 2021 VS 2028 Figure 5. Men Case Studies Figure 6. Women Case Studies Figure 7. Anti-obesity Medicine Report Years Considered Figure 8. Global Anti-obesity Medicine Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 9. Global Anti-obesity Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Anti-obesity Medicine Market Share by Region: 2021 VS 2028 Figure 11. Global Anti-obesity Medicine Market Share by Players in 2021 Figure 12. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-obesity Medicine as of 2021) Figure 13. The Top 10 and 5 Players Market Share by Anti-obesity Medicine Revenue in 2021 Figure 14. North America Anti-obesity Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 15. North America Anti-obesity Medicine Market Size Market Share by Type (2017-2028) Figure 16. North America Anti-obesity Medicine Market Size Market Share by Application (2017-2028) Figure 17. North America Anti-obesity Medicine Market Size Share by Country (2017-2028) Figure 18. United States Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Anti-obesity Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 21. Europe Anti-obesity Medicine Market Size Market Share by Type (2017-2028) Figure 22. Europe Anti-obesity Medicine Market Size Market Share by Application (2017-2028) Figure 23. Europe Anti-obesity Medicine Market Size Share by Country (2017-2028) Figure 24. Germany Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Anti-obesity Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 31. Asia Pacific Anti-obesity Medicine Market Size Market Share by Type (2017-2028) Figure 32. Asia Pacific Anti-obesity Medicine Market Size Market Share by Application (2017-2028) Figure 33. Asia Pacific Anti-obesity Medicine Market Size Share by Region (2017-2028) Figure 34. China Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Japan Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. South Korea Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Southeast Asia Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. India Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Australia Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 40. Latin America Anti-obesity Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 41. Latin America Anti-obesity Medicine Market Size Market Share by Type (2017-2028) Figure 42. Latin America Anti-obesity Medicine Market Size Market Share by Application (2017-2028) Figure 43. Latin America Anti-obesity Medicine Market Size Share by Country (2017-2028) Figure 44. Mexico Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Brazil Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Middle East & Africa Anti-obesity Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 47. Middle East and Africa Anti-obesity Medicine Market Size Market Share by Type (2017-2028) Figure 48. Middle East and Africa Anti-obesity Medicine Market Size Market Share by Application (2017-2028) Figure 49. Middle East and Africa Anti-obesity Medicine Market Size Share by Country (2017-2028) Figure 50. Turkey Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. UAE Anti-obesity Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Alizyme Revenue Growth Rate in Anti-obesity Medicine Business (2017-2022) Figure 54. Amylin Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2017-2022) Figure 55. Arena Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2017-2022) Figure 56. Boehringer Ingelheim Revenue Growth Rate in Anti-obesity Medicine Business (2017-2022) Figure 57. Eisai Revenue Growth Rate in Anti-obesity Medicine Business (2017-2022) Figure 58. GlaxoSmithKline Revenue Growth Rate in Anti-obesity Medicine Business (2017-2022) Figure 59. Orexigen Therapeutics Revenue Growth Rate in Anti-obesity Medicine Business (2017-2022) Figure 60. Vivus Revenue Growth Rate in Anti-obesity Medicine Business (2017-2022) Figure 61. Pfizer Revenue Growth Rate in Anti-obesity Medicine Business (2017-2022) Figure 62. Roche Revenue Growth Rate in Anti-obesity Medicine Business (2017-2022) Figure 63. Merck Revenue Growth Rate in Anti-obesity Medicine Business (2017-2022) Figure 64. Novo Nordisk Revenue Growth Rate in Anti-obesity Medicine Business (2017-2022) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Alizyme Amylin Pharmaceuticals Arena Pharmaceuticals Boehringer Ingelheim Eisai GlaxoSmithKline Orexigen Therapeutics Vivus Pfizer Roche Merck Novo Nordisk